Articles |
From the Pharmacology Group and Vascular Biology Research Centre, Division of Biomedical Sciences, King's College, London, UK.
Correspondence to Dr S.D. Brain, Pharmacology Group and Vascular Biology Research Centre, Division of Biomedical Sciences, King's College, Manresa Road, London SW3 6LX, UK.
Abstract The possible modulatory role of nitric oxide (NO) in neurogenic edema formation in rat paw skin, induced by electrical stimulation of the saphenous nerve, was investigated by using two NO synthase inhibitors, NG-nitro-L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI). Both L-NAME (100 mg/kg IV, P<.05) and 7-NI (10 mg/kg IV, P<.05) caused an L-arginine (100 mg/kg IV, P<.01)reversible inhibition of neurogenic edema as measured by 125I-albumin accumulation, whereas D-NAME (inactive enantiomer of L-NAME) and 6-aminoindazole (structurally similar to 7-NI) were without inhibitory effect. L-NAME produced the predicted vasopressor effect (before, 115±18 mm Hg; 5 minutes after, 174±18 mm Hg; n=6; P<.05), whereas 7-NI showed no significant increase in blood pressure (before, 96±9 mm Hg; 5 minutes after, 102±10 mm Hg; n=6), and neither L-NAME nor 7-NI had any effect on basal or vasodilator calcitonin gene-related peptide (CGRP, 10 pmol per site)stimulated local blood flow in rat skin, as measured by laser Doppler flowmetry. Furthermore, systemic and local 7-NI had no effect on edema formation induced by local administration of substance P (with or without CGRP) and histamine (with or without CGRP) in rat skin. Since 7-NI blocks edema produced by stimulation of the saphenous nerve, it is suggested that release of NO is involved in neurogenic edema formation, but the vasodilator action of NO is unimportant in this context. We suggest that NO is involved in the release of neuropeptides from sensory nerves.
Key Words: neurogenic inflammation nitric oxide substance P calcitonin gene-related peptide sensory nerves
This article has been cited by other articles:
![]() |
S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.T. Lundy and G.J. Linden NEUROPEPTIDES AND NEUROGENIC MECHANISMS IN ORAL AND PERIODONTAL INFLAMMATION Critical Reviews in Oral Biology & Medicine, March 1, 2004; 15(2): 82 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pelat, C. Dessy, P. Massion, J.-P. Desager, O. Feron, and J.-L. Balligand Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide-Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E-/- Mice In Vivo Circulation, May 20, 2003; 107(19): 2480 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner, E. C. Carnio, and L. G. S. Branco Role of neuronal nitric oxide synthase in hypoxia-induced anapyrexia in rats J Appl Physiol, September 1, 2000; 89(3): 1131 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Vaquero, X Molero, V Puig-Divi, and J-R Malagelada Contrasting effects of circulating nitric oxide and nitrergic transmission on exocrine pancreatic secretion in rats Gut, November 1, 1998; 43(5): 684 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kurihara, M. E. Alfie, D. H. Sigmon, N.-E. Rhaleb, E. G. Shesely, and O. A. Carretero Role of nNOS in Blood Pressure Regulation in eNOS Null Mutant Mice Hypertension, November 1, 1998; 32(5): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |